Muromonab-cd3 Alternatives Compared
Muromonab-cd3 | Myfortic (mycophenolic acid) | Mycophenolic acid |
|
---|
Muromonab-cd3 | Myfortic (mycophenolic acid) | Mycophenolic acid |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Rejection Prophylaxis, Rejection Reversal. Muromonab-cd3 may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Dermatomyositis, Rejection Prophylaxis. Myfortic may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Dermatomyositis, Rejection Prophylaxis. Mycophenolic acid may also be used for purposes not listed in this medication guide. |
Related suggestions Rejection Prophylaxis
|
|||||||||||||||
More about Muromonab-cd3 | More about Myfortic (mycophenolic acid) | More about Mycophenolic acid | ||||||||||||||||
Ratings & Reviews | ||||||||||||||||||
Be the first to share your experience with this drug. |
Myfortic has an average rating of 8.8 out of 10 from a total of 4 ratings on Drugs.com. 75% of reviewers reported a positive effect, while 0% reported a negative effect. |
Mycophenolic acid has an average rating of 8.8 out of 10 from a total of 8 ratings on Drugs.com. 75% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||
View all Muromonab-cd3 side effects |
View all Myfortic side effects |
View all Mycophenolic acid side effects |
||||||||||||||||
Drug Class | ||||||||||||||||||
Generic Availability | ||||||||||||||||||
N/A |
Lower cost generic |
|||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Myfortic prices |
View all Mycophenolic acid prices |
||||||||||||||||
Dosage Forms | ||||||||||||||||||
N/A |
|
|
||||||||||||||||
Brand Names | ||||||||||||||||||
N/A |
N/A |
Myfortic | ||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||
18 hours |
16 hours |
16 hours |
||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | ||||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | ||||||||||||||||||
A total of 174 drugs are known to interact with Muromonab-cd3:
|
A total of 338 drugs are known to interact with Myfortic:
|
A total of 338 drugs are known to interact with Mycophenolic acid:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
|
||||||||||||||||
Disease Interactions | ||||||||||||||||||
First Approval Date | ||||||||||||||||||
N/A |
February 27, 2004 |
February 27, 2004 |
||||||||||||||||
WADA Class View classifications | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
More Information | ||||||||||||||||||
Patient Resources | ||||||||||||||||||
Professional Resources | ||||||||||||||||||
N/A |
||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.